Vaccines

Nov 15, 2017
Pharmaceutical Technology
This article explores some of the challenges, services, and technologies that go into ensuring that vaccines are properly temperature controlled and maintain product integrity for delivery to patients.
Nov 15, 2017
Pharmaceutical Technology
Despite the challenges and high cost of development, vaccine innovation is at an all-time high, as new approaches aim to improve global access.
Nov 15, 2017
Pharmaceutical Technology
Challenge trials may increase in coming years as new and improved challenge agents better emulate “natural” disease states.
Nov 10, 2017
By Pharmaceutical Technology Editors
The company expects to commercially launch the new vaccine in the US in the first quarter of 2018.
Nov 03, 2017
By Pharmaceutical Technology Editors
The Human Vaccines Project has created the Universal Influenza Vaccine Initiative, a research program that will aim to understand the human immune system’s role in the development of universal influenza vaccines.
Oct 27, 2017
By Pharmaceutical Technology Editors
The vaccine is approved for the prevention of shingles in adult patients aged 50 years and older.
Oct 26, 2017
By Pharmaceutical Technology Editors
Inovio has reported results from a study with non-human primates that showed 100% effectiveness with a DNA vaccine the company is developing with the US Army.
Oct 20, 2017
By Pharmaceutical Technology Editors
The companies aim to use CureVac’s proprietary messenger RNA technology to develop and commercialize up to five potential cancer vaccine products.
Oct 19, 2017
By Pharmaceutical Technology Editors
The two companies announced their collaboration for the production and development of cancer vaccines.
Oct 16, 2017
By Pharmaceutical Technology Editors
The vaccine is a non-live, recombinant subunit vaccine that combines an antigen and an adjuvant system to trigger a targeted and long-lasting immune response to the shingle-causing virus.
native1_300x100
lorem ipsum